An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 5, 2011, Pages 324-334

  Kentrou, Nektaria A ^a   Tsagarakis, Nikolaos J ^a   Tzanetou, Konstantina ^a   Damala, Maria ^a   Papadimitriou, Konstantinos A ^a   Skoumi, Dimitra ^a   Stratigaki, Aimilia ^a   Anagnostopoulos, Nikolaos I ^a   Malamou Lada, Eleni ^a   Athanassiadou, Pauline ^b   Paterakis, George ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

atypical mesothelial cells; flow cytometry; malignant effusions

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD14 ANTIGEN; CD16 ANTIGEN; CD45 ANTIGEN; CD64 ANTIGEN; CYTOKERATIN; DNA; PROPIDIUM IODIDE;

ANEUPLOIDY; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CARCINOMA CELL; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EFFUSION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; PLOIDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; ASCITIC FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NEOPLASMS; PERICARDIAL EFFUSION; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 80051861521     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20608     Document Type: Article

References (41)

1. Chen LM, Lazcano O, Katzmann JA, Kimlinger TK, Li CY,. The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in the evaluation of body cavity fluids: A prospective study of 52 patients. Am J Clin Pathol 1998; 109: 712-721. (Pubitemid 28247270)
2. Krishan A, Ganjei-Azar P, Jorda M, Hamelik RM, Reis IM, Nadji M,. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis. Diagn Cytopathol 2006; 34: 528-541. (Pubitemid 44157173)
3. Kumar NU, Dey P, Mondal AK, Singh SK, Vohra H,. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma. Diagn Cytopathol 2001; 24: 153-156. (Pubitemid 32183150)
4. Saha I, Dey P, Vhora H, Nijhawan R,. Role of DNA flow cytometry and image cytometry on effusion fluid. Diagn Cytopathol 2000; 22: 81-85. (Pubitemid 30069048)
5. Joseph MG, Banerjee D, Harris P, Gibson S, McFadden RG,. Multiparameter flow cytometric DNA analysis of effusions: A prospective study of 36 cases compared with routine cytology and immunohistochemistry. Mod Pathol 1995; 8: 686-693.
6. O'Leary TJ,. Flow cytometry in diagnostic cytology. Diagn Cytopathol 1998; 18: 41-46. (Pubitemid 28028662)
7. Zarbo RJ,. Flow cytometric DNA analysis of effusions. A new test seeking validation. Am J Clin Pathol 1991; 95: 2-4.
8. Ceyhan BB, Demiralp E, Celikel T,. Analysis of pleural effusions using flow cytometry. Respiration 1996; 63: 17-24. (Pubitemid 26039582)
9. Sayed DM, el-Attar MM, Hussein AA,. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids. Diagn Cytopathol 2009; 37: 498-504.
10. Mohanty SK, Dey P,. Serous effusions: Diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 2003; 79: 569-574. (Pubitemid 37445251)
11. Motherby H, Nadjari B, Friegel P, et al. Diagnostic accuracy of effusion cytology. Diagn Cytopathol 1999; 20: 350-357. (Pubitemid 29239366)
12. Daniels TR, Delgado T, Helguera G, Penichet ML,. The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006; 121: 159-176. (Pubitemid 44572972)
13. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML,. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006; 121: 144-158. (Pubitemid 44592578)
14. Testa U, Pelosi E, Peschle C,. The transferrin receptor. Crit Rev Oncog 1993; 4: 241-276.
15. Suassuna JH, Das Neves FC, Hartley RB, Ogg CS, Cameron JS,. Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 1994; 46: 443-454. (Pubitemid 24253051)
16. Frankenberger M, Passlick B, Hofer T, et al. Immunologic characterization of normal human pleural macrophages. Am J Respir Cell Mol Biol 2000; 23: 419-426.
17. van Ravenswaay Claasen HH, Kluin PM, Fleuren GJ,. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest 1992; 67: 166-174.
18. Davis BH,. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 2005; 5: 193-207. (Pubitemid 40396225)
19. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000; 15: 166-169. (Pubitemid 30068955)
20. Lazcano O, Chen LM, Tsai C, et al. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: Reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions. Mod Pathol 2000; 13: 788-796. (Pubitemid 30470169)
21. Davidson B, Nielsen S, Christensen J, et al. The role of desmin and N-cadherin in effusion cytology: A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001; 25: 1405-1412. (Pubitemid 33022056)
22. Bryson GJ, Lear D, Williamson R, Wong RC,. Detection of the CD56+/. J Clin Pathol 2002; 55: 535-537.
23. Fiegl M, Zojer N, Kaufmann H, et al. Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH). Cytometry 1999; 38: 15-23. (Pubitemid 29114256)
24. Czader M, Ali SZ,. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions. Diagn Cytopathol 2003; 29: 74-78. (Pubitemid 36988082)
25. Davidson B, Dong HP, Holth A, Berner A, Risberg B,. Flow cytometric immunophenotyping of cancer cells in effusion specimens: Diagnostic and research applications. Diagn Cytopathol 2007; 35: 568-578. (Pubitemid 47435621)
26. Dong HP, Holth A, Berner A, Davidson B, Risberg B,. Flow cytometric immunphenotyping of epithelial cancer cells in effusions-technical considerations and pitfalls. Cytometry Part B Clin Cytom 2007; 72B: 332-343. (Pubitemid 350194350)
27. Frey T,. Nucleic acid dyes for detection of apoptosis in live cells. Cytometry 1995; 21: 265-274.
28. Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV,. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992; 13: 204-208.
29. Sparrow RL, Tippett E,. Discrimination of live and early apoptotic mononuclear cells by the fluorescent SYTO 16 vital dye. J Immunol Methods 2005; 305: 173-187. (Pubitemid 41416712)
30. van der Pol MA, Broxterman HJ, Westra G, Ossenkoppele GJ, Schuurhuis GJ,. Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples. Cytometry Part B Clin Cytom 2003; 55B: 14-21. (Pubitemid 38295404)
31. Attanoos RL, Griffin A, Gibbs AR,. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003; 43: 231-238. (Pubitemid 37115056)
32. Sigstad E, Dong HP, Nielsen S, et al. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping. Diagn Cytopathol 2005; 33: 325-331. (Pubitemid 41598053)
33. Risberg B, Davidson B, Dong HP, Nesland JM, Berner A,. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: Comparison with immunocytochemistry and morphological findings. J Clin Pathol 2000; 53: 513-517. (Pubitemid 30432108)
34. Saleh HA, El-Fakharany M, Makki H, Kadhim A, Masood S,. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: The utility of immunocytochemical panel in the differential diagnosis. Diagn Cytopathol 2009; 37: 324-332.
35. Daste G, Serre G, Mauduyt MA, et al. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin. CEA and EMA improves the cytodiagnosis of serous effusions. Cytopathology 1991; 2: 19-28.
36. Dejmek A, Hjerpe A,. The combination of CEA. EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Diagn Cytopathol 2005; 32: 160-166. (Pubitemid 40256266)
37. Illingworth AL, Young JA, Johnson GD,. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody. AUA-1 and Ber-EP4. Cytopathology 1994; 5: 270-281. (Pubitemid 24301545)
38. Singh HK, Silverman JF, Berns L, Haddad MG, Park HK,. Significance of epithelial membrane antigen in the work-up of problematic serous effusions. Diagn Cytopathol 1995; 13: 3-7.
39. Thunnissen FB, Buchholtz RT, Woutersen DP, et al. Clinical value of DNA image cytometry in effusions with atypia. Diagn Cytopathol 1999; 21: 112-116. (Pubitemid 29355037)
40. Pissaia A Jr., Bernard D, Scatton O, et al. Significance of serum tumor markers carcinoembryonic antigen. CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation. Transplant Proc 2009; 41: 682-684.
41. Welander CE,. What do CA 125 and other antigens tell us about ovarian cancer biology? Acta Obstet Gynecol Scand Suppl 1992; 155: 85-93.